About
Male
Dr. Michael Carter joined SVLS in 1998 as a Venture Partner. From 1986 to 1998 Michael was on the board of ICI/Zeneca Pharmaceuticals and from 1995 - 1998 was also a board member of Salick Healthcare - a US subsidiary of Zeneca. He was International Marketing Director at ICI/Zeneca Pharmaceuticals; in addition as International Medical Director he was involved in the clinical and commercial development of over 20 new medicines. For 10 years (1986 - 1996) he was a member of the UK Government's Medicines Commission. He has also worked at Roche Products as Director of the Pharmaceutical Division. Before entering the pharmaceutical industry, Michael practiced as a physician for eleven years. Michael is currently on the boards of GTx Inc, Oxagen / Atopix, Oncoethix, Santarus Inc. and a member of the Strategic Advisory Board of Healthcare Royalty Partners. Previously Dr Carter was on the boards of CancerVax, Genosis, Fulcrum, KuDOS, Micromet and Warner Chilcott.
Experience
SV Health Investors
View →Venture Partner · 1998 – present
76Boston, Massachusetts, United StatesBiotechnology · Health Care
- Director · OncoEthix2013 – present
- Director and Chairman of Compensation Committee · GTx2006 – present
- Former Director and Member of Compensation Committee · CancerVax2001 – present
Education
- UCL School of Pharmacy · BS, unknown
- University of Sheffield · MS, unknown
People at SV Health Investors
Data from: crunchbase
